Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute for Genomic Medicine |
RCV001290354 | SCV001478400 | pathogenic | Vascular Malformations and Overgrowth | 2020-11-08 | no assertion criteria provided | research | This alteration is of apparent somatic mosaic etiology with strong supporting evidence including no discernible strand bias, in a region absent of repetition and sequence homology, with clean, high-quality reads, having a variant allele fraction >= 3% [PS2], is supported by well-established models demonstrating downstream impact of the variant on RNA structure, gene expression, or protein function [PS3], is either well-represented in cancer as identified in the COSMIC database with >=20 documented instances or considered to occur in a statistically significant hotspot or region according to cancerhotspots.org database [PM_CANCER], and is in a non-repetitive region and results in a protein length change predicted to result in an in-frame protein product [PM4]. |
Vascular Anomalies Center, |
RCV002221158 | SCV002498580 | likely pathogenic | CLOVES syndrome | 2022-01-16 | no assertion criteria provided | clinical testing |